Highly qualified team with experience in technology transfer
OWNED TECHNOLOGY 3 patent families
that help us in the development of applications in the biomedical sector.
In the core of a strategic network qualified to cover the whole value chain
to reduce the time to market
165 m2 plant for the manufacturing of medical products under research operating under GMP standards.
A campaign production has been designed for a flexible production of:
CIDETEC is a leader in the development of nanotechnology for the administration of drugs via pulmonary route.
Drug-delivery via inhalation
Intelligent release systems for increased effectiveness of the active ingredients in cosmetics and dermocosmetics.
Drug-delivery via skin
Highly hydrophilic coatings that mimic the surface of the cartilage and reduce the wear of the prosthesis up to 80%.
Coatings for prostheses
CIDETEC has specialized, cutting edge equipment and a pilot plant operating under GMP for the manufacturing of drugs at research stages.
GMP Manufacturing
Drug-delivery via inhalation
Lung administration
Pros
Cons
Advantages of nanotechnology:
CIDETEC has developed a technology based on polymer nanoparticles that are obtained from natural polymers of very high biocompatibility.
Because of their small size, under 50 nm, they have a great diffusion capacity, being able to reach the alveoli homogeneously.
This technology allows obtaining particles of low polydispersity in an easily scalable process that takes place in water and is therefore easily adaptable to the requirements of good manufacturing.
Natural active principles
Pros
Cons
The encapsulation systems developed to improve their performance do not respond to the needs of the skin and do not increase the absorption of the active ingredients.
CIDETEC in collaboration with the Laboratory of Chemistry of Organic Polymers of the University of Bordeaux (France) has developed a new system of intelligent nanocapsules.
Encapsulation extends the activity of active substances by 30% and responds to the needs of the skin releasing the active principles where they are most needed.
The systems allow an efficiency of almost 100% encapsulation. Due to their nanometric size they penetrate the skin better and completely degrade once they release the active principle, avoiding possible side effects from the use of nanoparticles.
Polyethylene joint prostheses
Pros
Cons
Mimicking the surface of natural joints, CIDETEC has developed a technology that maintains the surface of the friction torque of prostheses permanently lubricated and hydrated.
The coating is highly biocompatible and does not alter the synovial fluid and its natural lubricants and also avoids the non-specific adsorption of proteins.
The coatings have been tested on a test bench for five million cycles, reducing the polyethylene wear rate by up to 80% over non-coated material.
SMEs in the pharmaceutical sector
Pros
Cons
Launching a pharmaceutical product onto the market can cost millions of euros over a period of 15 years.
CIDETEC has a multidisciplinary team who are experts in the transfer of technology in the field of nanomedicine and biomaterials from the laboratory scale to the first clinical batches.
The centre has a pilot plant that operates according to GMP standards for the manufacture of small batches of research drugs aimed at initial clinical phases.
In this way, CIDETEC helps companies put their products on the market, faster and at a lower cost.
